1 min read
JPSC Drug Inspector Recruitment 2026
JPSC Drug Inspector Recruitment 2026: 30 posts open! Apply online by Feb 18 for B.Pharm graduates. Check eligibility, syllabus, and salary on jpsc.gov.in now.
Post Summary
Jharkhand Public Service Commission (JPSC) has released the notification for the recruitment of Drug Inspector 2026 on the official website. This recruitment has 30 positions. The JPSC application form has started from 29th January 2026, and candidates can apply until 18th February 2026. Candidates must check the complete details for the JPSC Drug Inspector Recruitment 2026 provided below.
Important Dates
Online Apply Start Date :29 January 2026
Online Apply Last Date :18 February 2026
Last Date for Fee Payment :19 February 2026
Application Fees
General / BC / EBC / EWS: :₹ 600 /-
SC / ST(Only Jharkhand State): :₹ 150 /-
Vacancy Details
| Post Name | No. of Post | Eligibility Criteria |
|---|---|---|
| JPSC Drug Inspector | 30 | Candidates must have a Bachelor’s degree in Pharmacy, Pharmaceutical Sciences, or Medicine with Clinical Pharmacology or Microbiology from any recognized university in India. |
Important Links
| Link Name | Status |
|---|---|
| One Time Registration Link | Click Here |
| Official Website | Click Here |
| Official Notification Page | Click Here |
Frequently Asked Questions
Who qualifies for JPSC Drug Inspector 2026 with B.Pharm?
B.Pharm or Pharm.D graduates aged 21-40 (relaxations apply) with 18 months experience can apply.
What's the last date for JPSC Drug Inspector online form 2026?
Submit online by Feb 18, 2026, 5 p.m. via the OTR portal, then provide a hard copy to JPSC Ranchi by March 5.
How many JPSC Drug Inspector posts are there in 2026?
30 posts (25 unreserved, 5 reserved) under Advt. 12/2025; apply via jpsc.gov.in.
When is JPSC Drug Inspector 2026 exam date announced?
No date yet; expect prelims post applications, check syllabus for pharma laws, drugs, and G.K. on it's official website.
Community Discussion
0 commentsJoin the conversation
Loading authentication...
No comments yet
Start the conversation by posting the first comment!